Literature DB >> 22430298

Energy metabolism and proliferation in pancreatic carcinogenesis.

Ivonne Regel1, Bo Kong, Susanne Raulefs, Mert Erkan, Christoph W Michalski, Mark Hartel, Jörg Kleeff.   

Abstract

INTRODUCTION: Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer entity with a high proliferative potential. Uncontrolled cell proliferation is mediated by a number of core signaling pathways. Recently, novel data of PDAC biology suggest that these core signal pathways affect cell proliferation and metabolism simultaneously.
METHODS: Here, we reviewed the literature on core metabolic signaling pathways in pancreatic carcinogenesis.
RESULTS: Results obtained from mouse genetics and in vitro experiments have demonstrated the significance of the Kras, p53, c-Myc, and Lkb1 networks in the proliferation of pancreatic epithelial and cancer cells. At the same time, these major pathways also affect energy metabolism by influencing glucose and glutamine utilization. In particular, Kras-mediated metabolic changes seem to be directly involved in carcinogenesis. However, there is a lack of solid evidence on how metabolism and proliferation are connected in pancreatic carcinogenesis.
CONCLUSION: Understanding early and subtle changes in cellular metabolism of pancreatic epithelial-and specifically of acinar-cells, which accompany or directly influence malignant transformation and uncontrolled proliferation, will be paramount to define novel imaging and other modalities for earlier detection of PDAC.

Entities:  

Mesh:

Year:  2012        PMID: 22430298     DOI: 10.1007/s00423-012-0933-9

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  61 in total

1.  Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability.

Authors:  R Sears; F Nuckolls; E Haura; Y Taya; K Tamai; J R Nevins
Journal:  Genes Dev       Date:  2000-10-01       Impact factor: 11.361

Review 2.  Reflecting on 25 years with MYC.

Authors:  Natalie Meyer; Linda Z Penn
Journal:  Nat Rev Cancer       Date:  2008-12       Impact factor: 60.716

Review 3.  The LKB1 tumor suppressor kinase in human disease.

Authors:  Pekka Katajisto; Tea Vallenius; Kari Vaahtomeri; Niklas Ekman; Lina Udd; Marianne Tiainen; Tomi P Mäkelä
Journal:  Biochim Biophys Acta       Date:  2006-08-16

4.  Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues.

Authors:  Michaela Aichler; Christopher Seiler; Monica Tost; Jens Siveke; Pawel K Mazur; Patricia Da Silva-Buttkus; Detlef K Bartsch; Peter Langer; Sara Chiblak; Anna Dürr; Heinz Höfler; Günter Klöppel; Karin Müller-Decker; Markus Brielmeier; Irene Esposito
Journal:  J Pathol       Date:  2012-01-17       Impact factor: 7.996

5.  Proteomic analysis reveals Warburg effect and anomalous metabolism of glutamine in pancreatic cancer cells.

Authors:  Weidong Zhou; Michela Capello; Claudia Fredolini; Leda Racanicchi; Lorenzo Piemonti; Lance A Liotta; Francesco Novelli; Emanuel F Petricoin
Journal:  J Proteome Res       Date:  2011-11-17       Impact factor: 4.466

6.  The Lkb1 metabolic sensor maintains haematopoietic stem cell survival.

Authors:  Sushma Gurumurthy; Stephanie Z Xie; Brinda Alagesan; Judith Kim; Rushdia Z Yusuf; Borja Saez; Alexandros Tzatsos; Fatih Ozsolak; Patrice Milos; Francesco Ferrari; Peter J Park; Orian S Shirihai; David T Scadden; Nabeel Bardeesy
Journal:  Nature       Date:  2010-12-02       Impact factor: 49.962

7.  Ras-dependent carbon metabolism and transformation in mouse fibroblasts.

Authors:  F Chiaradonna; E Sacco; R Manzoni; M Giorgio; M Vanoni; L Alberghina
Journal:  Oncogene       Date:  2006-04-10       Impact factor: 9.867

Review 8.  The biology of cancer: metabolic reprogramming fuels cell growth and proliferation.

Authors:  Ralph J DeBerardinis; Julian J Lum; Georgia Hatzivassiliou; Craig B Thompson
Journal:  Cell Metab       Date:  2008-01       Impact factor: 27.287

9.  LKB1 haploinsufficiency cooperates with Kras to promote pancreatic cancer through suppression of p21-dependent growth arrest.

Authors:  Jennifer P Morton; Nigel B Jamieson; Saadia A Karim; Dimitris Athineos; Rachel A Ridgway; Colin Nixon; Colin J McKay; Ross Carter; Valerie G Brunton; Margaret C Frame; Alan Ashworth; Karin A Oien; T R Jeffry Evans; Owen J Sansom
Journal:  Gastroenterology       Date:  2010-05-06       Impact factor: 22.682

10.  PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum.

Authors:  M F Offield; T L Jetton; P A Labosky; M Ray; R W Stein; M A Magnuson; B L Hogan; C V Wright
Journal:  Development       Date:  1996-03       Impact factor: 6.868

View more
  12 in total

1.  Homeodomain-interacting protein kinase 2 suppresses proliferation and aerobic glycolysis via ERK/cMyc axis in pancreatic cancer.

Authors:  Yi Qin; Qiangsheng Hu; Shunrong Ji; Jin Xu; Weixing Dai; Wensheng Liu; Wenyan Xu; Qiqing Sun; Zheng Zhang; Quanxing Ni; Xianjun Yu; Bo Zhang; Xiaowu Xu
Journal:  Cell Prolif       Date:  2019-04-01       Impact factor: 6.831

Review 2.  New insights into pancreatic cancer-induced paraneoplastic diabetes.

Authors:  Raghuwansh P Sah; Sajan Jiv Singh Nagpal; Debabrata Mukhopadhyay; Suresh T Chari
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-03-26       Impact factor: 46.802

Review 3.  KRAS: feeding pancreatic cancer proliferation.

Authors:  Kirsten L Bryant; Joseph D Mancias; Alec C Kimmelman; Channing J Der
Journal:  Trends Biochem Sci       Date:  2014-01-02       Impact factor: 13.807

4.  Profiling and targeting of cellular bioenergetics: inhibition of pancreatic cancer cell proliferation.

Authors:  G Cheng; J Zielonka; D McAllister; S Tsai; M B Dwinell; B Kalyanaraman
Journal:  Br J Cancer       Date:  2014-05-27       Impact factor: 7.640

5.  Diabetes and pancreatic cancer survival: a prospective cohort-based study.

Authors:  A T Toriola; R Stolzenberg-Solomon; L Dalidowitz; D Linehan; G Colditz
Journal:  Br J Cancer       Date:  2014-05-01       Impact factor: 7.640

Review 6.  Blood glucose concentration and risk of pancreatic cancer: systematic review and dose-response meta-analysis.

Authors:  Wei-Chih Liao; Yu-Kang Tu; Ming-Shiang Wu; Jaw-Town Lin; Hsiu-Po Wang; Kuo-Liong Chien
Journal:  BMJ       Date:  2015-01-02

7.  A pilot study of radiologic measures of abdominal adiposity: weighty contributors to early pancreatic carcinogenesis worth evaluating?

Authors:  Jennifer B Permuth; Jung W Choi; Dung-Tsa Chen; Kun Jiang; Gina DeNicola; Jian-Nong Li; Domenico Coppola; Barbara A Centeno; Anthony Magliocco; Yoganand Balagurunathan; Nipun Merchant; Jose G Trevino; Daniel Jeong
Journal:  Cancer Biol Med       Date:  2017-02       Impact factor: 4.248

8.  Impact of postoperative glycemic control and nutritional status on clinical outcomes after total pancreatectomy.

Authors:  Hao-Jun Shi; Chen Jin; De-Liang Fu
Journal:  World J Gastroenterol       Date:  2017-01-14       Impact factor: 5.742

9.  Relationship between pancreatic cancer-associated diabetes and cachexia.

Authors:  Wei-Chih Liao; Peng-Ruei Chen; Cheng-Chieh Huang; Yen-Tzu Chang; Bo-Shih Huang; Chin-Chen Chang; Ming-Shiang Wu; Lu-Ping Chow
Journal:  J Cachexia Sarcopenia Muscle       Date:  2020-02-25       Impact factor: 12.910

Review 10.  Risk factors and therapeutic targets in pancreatic cancer.

Authors:  Sonja Maria Wörmann; Hana Algül
Journal:  Front Oncol       Date:  2013-11-18       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.